India must make medicines affordable without undermining pharmaceutical innovation. A fragmented pricing regime leaves patients exposed and the industry uncertain about its future
Rakesh Khar
October 21, 2026 at 6:12 AM IST
istock.com
BasisPoint Insight
July 22, 2026 at 3:20 AM IST
Indian pharma companies, and the regulatory and judicial support system, must wake up to the challenges of personalised medicines and the changes this would necessitate in formulating and approving drug trials and patenting of drugs and production processes.
TK Arun
January 28, 2026 at 10:02 AM IST
iStock.com
